Clinical Trials Browser

Melanoma × tetraethylpyrazine × Dermatologic × Clear all

NCT04581382 2025-07-10

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

Phase EARLY_PHASE1 Completed

Melanoma